Study on the Therapeutic Effect of Irinotecan Liposomes in Small Cell Lung Cancer

NCT06467786 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Small Cell Lung Cancer

Interventions

DRUG: Irinotecan hydrochloride liposome injection

Sponsor

Tang-Du Hospital